| Line item | 2026-01-31 FY | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $2.62M | $4.72M | $3.00M | $4.15M | $74.71K | $121.79K |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | $74.71K | $121.79K |
| Operating Income | -$2.62M | -$4.72M | -$3.00M | -$4.15M | -$74.71K | -$121.79K |
| Interest Expense | – | – | $401.04K | $340.95K | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$3.07M | -$5.14M | -$3.71M | -$4.30M | -$74.71K | -$121.79K |
| EPS (basic) | -0.2300 | -0.0200 | -0.0200 | -0.1800 | 0.0000 | -0.0100 |
| EPS (diluted) | -0.2300 | -0.0200 | -0.0200 | -0.1800 | 0.0000 | -0.0100 |
| Shares (diluted) | $13.43M | $247.03M | $211.29M | $24.18M | $20.05M | $20.05M |